Aurinia Pharmaceuticals Inc.
DE ˙ DB ˙ CA05156V1022
13,91 € ↑0,53 (3,96%)
2026-06-04
DEL PRIS
SecurityDE:IKAP / Aurinia Pharmaceuticals Inc.
InstitutionCreative Planning
Latest Disclosed Ownership38,644 shares
Latest Disclosed Value $ 572,711
Creative Planning reports 55.56% increase in ownership of IKAP / Aurinia Pharmaceuticals Inc.

On May 12, 2026 - Creative Planning filed a 13F-HR form disclosing ownership of 38,644 shares of Aurinia Pharmaceuticals Inc. (DE:IKAP) valued at $490,779 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 24,842 shares of Aurinia Pharmaceuticals Inc.. This represents a change in shares of 55.56% during the quarter. The current value of the position is $537,538 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 38,644 13,802 55.56 573 44.44 0.0004
2026-02-17 2025-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 24,842 -828 -3.23 396 39.93 0.0003
2025-11-14 2025-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 25,670 4,971 24.02 284 61.71 0.0002
2025-08-08 2025-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 20,699 3,594 21.01 175 27.74 0.0001
2025-05-15 2025-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 17,105 973 6.03 138 -4.86 0.0001
2025-02-14 2024-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 16,132 1,451 9.88 145 34.58 0.0001
2024-10-11 2024-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 14,681 -664 -4.33 108 22.99 0.0001
2024-08-15 2024-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 15,345 15,345 88 0.0001
2024-05-13 2024-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 0 -11,384 -100.00 0 -100.00
2024-02-14 2023-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 11,384 11,384 102 0.0002
2021-08-04 2021-06-30 13F CreativePlanning COM 05156V102 0 -64,130 -100.00 0 -100.00
2021-04-30 2021-03-31 13F CreativePlanning COM 05156V102 64,130 2,995 4.90 833 -1.42 0.0017
2021-01-29 2020-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 61,135 -11,285 -15.58 845 -20.81 0.0019
2020-11-05 2020-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 72,420 4,220 6.19 1,067 -3.70 0.0028
2020-07-23 2020-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 68,200 -300 -0.44 1,108 11.47 0.0032
2020-05-05 2020-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 68,500 -197,200 -74.22 994 -81.53 0.0035
2020-01-30 2019-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 265,700 57,000 27.31 5,383 383.21 0.0162
2019-11-01 2019-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 208,700 0 0.00 1,114 -18.86 0.0036
2019-07-26 2019-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 208,700 0 0.00 1,373 1.18 0.0046
2019-04-24 2019-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 208,700 41,043 24.48 1,357 18.72 0.0049
2019-02-12 2018-12-31 13F/A-1 AURINIA PHARMACEUTICALS COM 05156V102 167,657 15,457 10.16 1,143 13.06 0.0047
2019-02-01 2018-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 167,657 15,457 1,143
2018-10-25 2018-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 152,200 -19,000 -11.10 1,011 4.88 0.0038
2018-07-20 2018-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 171,200 13,000 8.22 964 17.42 0.0038
2018-04-18 2018-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 158,200 8,000 5.33 821 20.20 0.0033
2018-01-17 2017-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 150,200 0 0.00 683 -27.49 0.0029
2017-10-17 2017-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 150,200 -14,065 -8.56 942 -6.45 0.0044
2017-07-12 2017-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 164,265 161,765 6,470.60 1,007 5,494.44 0.0051
2017-04-07 2017-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 2,500 1,500 150.00 18 800.00 0.0001
2017-01-09 2016-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 1,000 -59,000 -98.33 2 -98.90 0.0000
2016-10-12 2016-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 60,000 60,000 181 0.0012
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.